Stocks and Investing Stocks and Investing
Tue, September 17, 2024
Mon, September 16, 2024

Douglas Tsao Reiterated (TBPH) at Strong Buy and Held Target at $15 on, Sep 16th, 2024


Published on 2024-10-28 14:17:36 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of HC Wainwright & Co., Reiterated "Theravance Biopharma, Inc." (TBPH) at Strong Buy and Held Target at $15 on, Sep 16th, 2024.

Douglas has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, all agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Risinger of "Leerink Partners" Downgraded from Buy to Hold and Decreased Target to $10 on, Tuesday, August 6th, 2024
  • Marc Frahm of "TD Cowen" Maintained at Hold with Decreased Target to $9 on, Tuesday, August 6th, 2024
Contributing Sources